These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22231830)

  • 61. Brain-immune interactions in neuropsychiatric disorders: Lessons from transcriptome studies for molecular targeting.
    Afridi R; Seol S; Kang HJ; Suk K
    Biochem Pharmacol; 2021 Jun; 188():114532. PubMed ID: 33773976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oxidative stress: a potential link between emotional wellbeing and immune response.
    Salim S
    Curr Opin Pharmacol; 2016 Aug; 29():70-6. PubMed ID: 27400336
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Editorial commentary: "What does immunology have to do with brain development and neuropsychiatric disorders?".
    Leckman JF; Vaccarino FM
    Brain Res; 2015 Aug; 1617():1-6. PubMed ID: 25283746
    [No Abstract]   [Full Text] [Related]  

  • 64. Animal models for neuropsychiatric disorders: prospects for circuit intervention.
    Kaiser T; Zhou Y; Feng G
    Curr Opin Neurobiol; 2017 Aug; 45():59-65. PubMed ID: 28419975
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The immune system is a key factor in the etiology of psychosocial disease.
    Smith RS
    Med Hypotheses; 1991 Jan; 34(1):49-57. PubMed ID: 2056927
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Harm or heal--divergent effects of autoimmune neuroinflammation?
    Olsson T; Lidman O; Piehl F
    Trends Immunol; 2003 Jan; 24(1):5-6; author reply 7-8. PubMed ID: 12495713
    [No Abstract]   [Full Text] [Related]  

  • 67. Metabolic responses in the cortex and hippocampus induced by Il-15rα mutation.
    He Y; Ge L; Tong F; Zheng P; Yang J; Zhou J; Sun Z; Wang H; Yang S; Li Y; Yu Y
    Mol Omics; 2022 Oct; 18(9):865-872. PubMed ID: 35972394
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transgenic models for cytokine-induced neurological disease.
    Campbell IL; Hofer MJ; Pagenstecher A
    Biochim Biophys Acta; 2010 Oct; 1802(10):903-17. PubMed ID: 19835956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IL-4 in the brain: a cytokine to remember.
    Gadani SP; Cronk JC; Norris GT; Kipnis J
    J Immunol; 2012 Nov; 189(9):4213-9. PubMed ID: 23087426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms.
    Capuron L; Castanon N
    Curr Top Behav Neurosci; 2017; 31():31-44. PubMed ID: 27221626
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The mouse as a model for neuropsychiatric drug development.
    Howe JR; Bear MF; Golshani P; Klann E; Lipton SA; Mucke L; Sahin M; Silva AJ
    Curr Biol; 2018 Sep; 28(17):R909-R914. PubMed ID: 30205056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modern proteomic strategies in the study of complex neuropsychiatric disorders.
    Rohlff C; Hollis K
    Biol Psychiatry; 2003 May; 53(10):847-53. PubMed ID: 12742671
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Neuropsychiatry as the interface of behavioral manifestations driven by brain dysfunction.].
    Pasquini M; Berardelli I; Biondi M; Fabbrini G
    Riv Psichiatr; 2022; 57(2):106-114. PubMed ID: 35426430
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aluminum as a CNS and Immune System Toxin Across the Life Span.
    Shaw CA
    Adv Exp Med Biol; 2018; 1091():53-83. PubMed ID: 30315449
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Commentary: Are ADHD symptoms habit-like? A commentary on Goodman et al (2014).
    Tannock R
    J Child Psychol Psychiatry; 2014 Jun; 55(6):611-4. PubMed ID: 24840171
    [No Abstract]   [Full Text] [Related]  

  • 76. Molecular biology research in neuropsychiatry: India's contribution.
    Sathyanarayana Rao TS; Ramesh BN; Vasudevaraju P; Rao KS
    Indian J Psychiatry; 2010 Jan; 52(Suppl 1):S120-7. PubMed ID: 21836667
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inspiration for the prevention and treatment of neuropsychiatric disorders: New insight from the bone-brain-axis.
    Zhao Y; Suo Y; Yang Z; Hao Y; Li W; Su Y; Shi Y; Gao Y; Song L; Yin X; Shi H
    Brain Res Bull; 2021 Dec; 177():263-272. PubMed ID: 34678443
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Crosstalk between metabolic and neuropsychiatric disorders.
    Kaidanovich-Beilin O; Cha DS; McIntyre RS
    F1000 Biol Rep; 2012; 4():14. PubMed ID: 22802875
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Are cytokines associated with neuropsychiatric syndromes in humans?
    Hickie I; Lloyd A
    Int J Immunopharmacol; 1995 Aug; 17(8):677-83. PubMed ID: 8847162
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brain-immune interactions in neuropsychiatry: highlights of the basic science and relevance to pathogenic factors and epiphenomena.
    Petitto JM; Repetto MJ; Hartemink DA
    CNS Spectr; 2001 May; 6(5):383-8, 391. PubMed ID: 15999026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.